Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
BOSTON Seidler Berstein said it has added an assignment from Genzyme’s biosurgery division.
Genzyme tapped the independent marketing communications agency in Cambridge, Mass., to launch its Sepramesh IP hernia repair product. Agency initiatives will include market research, overall positioning, creative platform development, advertising, collateral and trade show support.
“Building on Genzyme’s unique position as a provider of biotech solutions coupled with device innovation, we are confident that the marketplace will be interested in Sepramesh IP,” said Seidler Bernstein’s director of account planning, Christopher Dimmock.
Ad
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in